Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.260
+0.020 (0.89%)
At close: May 16, 2025, 4:00 PM
2.249
-0.011 (-0.47%)
After-hours: May 16, 2025, 7:41 PM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $768.99 million as of May 16, 2025. Its market cap has decreased by -2.07% in one year.
Market Cap
768.99M
Enterprise Value
318.73M
1-Year Change
-2.07%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $768.99M, an increase of 340.74%. That is a compound annual growth rate of 36.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 762.19M | -14.86% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.44B |
| Johnson & Johnson | 363.75B |
| AbbVie | 321.61B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 252.81B |
| Abbott Laboratories | 232.18B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |